Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | RXT | BRUN |
|---|---|---|
| Price | $3.85 | $13.75 |
| Change today | ▼ 4.23% | ▼ 9.36% |
| Market cap | $981.26M | $1.09B |
| Return, 3 months | -11.9% | -54.5% |
| Return, year to date | +296.5% | +8.8% |
| Return, 1 year | +156.7% | +7.0% |
| P/E (TTM) | -5.9 | -25.9 |
| P/B | -0.8 | 10.9 |
| P/E percentile vs own 5y | 24th | 96th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +0.6% | +269.7% |
| Net profit growth (YoY) | -23.9% | -3,066.3% |
| Gross margin | 17.9% | 89.5% |
| Operating margin | -3.3% | -53.4% |
| Net margin | -5.9% | -173.7% |
| Return on equity | – | -97.9% |
| Analyst target vs. price | +33.8% | +205.5% |
| Analyst buy share | 0% | 100% |
| RSI (14) | 51 | 37 |
| 30-day volatility | 77.9% | 114.6% |
| Max drawdown, 1 year | -77.7% | -65.4% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
